MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Chronic directional subthalamic nucleus deep brain stimulation in Parkinson’s disease – A pilot study

    P. Reker, T.A. Dembek, A. Gierich, J. Wirths, H.S. Dafsari, J. Roediger, M.T. Barbe, L. Timmermann, V. Visser-Vandewalle (Cologne, Germany)

    Objective: This pilot study aimed to assess the therapeutic potential of chronically implanted directional DBS leads in patients with Parkinson's disease. Background: The therapeutic effect…
  • 2016 International Congress

    Clinical characteristics of Parkinson’s disease and essential tremor patients undergoing deep brain stimulation surgery: Five-year data from Columbia University Medical Center (2009 – 2014)

    M. Kestenbaum, D. Robakis, B. Ford, R.N. Alcalay, E.D. Louis (Tel Aviv, Israel)

    Objective: To compare the clinical characteristics of essential tremor (ET) and Parkinson's disease (PD) patients who underwent deep brain stimulation (DBS) surgery to those of…
  • 2016 International Congress

    Identification of unique metabolite signatures in post-mortem DBS human tissue using LC-HRMS

    V. Vedam-Mai, S. Sternberg, M. Williams, T. Garrett, M.S. Okun (Gainesville, FL, USA)

    Objective: Metabolomics is applied to the study of metabolic as well as neurodegenerative diseases. We propose to utilize this technique to detect metabolic changes from…
  • 2016 International Congress

    Neurophysiological assessment of corticospinal tract activation due to subthalamic deep brain stimulation in patients with Parkinson’s disease

    P. Mahlknecht, H. Akram, D. Georgiev, J. Candelario, A. Zacharia, Z. Kefalopoulou, L. Zrinzo, J. Hyam, M. Hariz, C. Milabo, T. Foltynie, J.C. Rothwell, P. Limousin (Innsbruck, Austria)

    Objective: To assess current spread to the corticospinal tract (CST) in patients with Parkinson's disease (PD) treated with bilateral Deep Brain Stimulation (DBS) of the…
  • 2016 International Congress

    Speech 10 years post bilateral STN-DBS for Parkinson’s disease

    E. Tripoliti, P. Mahlknecht, L. Zrinzo, M. Hariz, T. Foltynie, J. Candelario, P. Limousin (London, United Kingdom)

    Objective: This study reports on the type and severity of speech problems up to 10 years after bilateral deep brain stimulation (DBS) of the subthalamic…
  • 2016 International Congress

    Neuropsychological safety of bilateral pallidal (GPi) deep brain stimulation (DBS) for Parkinson’s disease (PD) under general anesthesia

    A.I. Tröster, F.A. Ponce, L. Autry, M. Lambert, V.G. Evidente, S. Oravivattanakul, A. Lieberman, G. Moguel-Cobos, N. Salins, K. Hanson (Phoenix, AZ, USA)

    Objective: To evaluate neuropsychological outcome of bilateral GPi DBS carried out under general anesthesia using a combination of direct anatomical targeting and intraoperative computed tomography…
  • 2016 International Congress

    Clinical outcome of constant current deep brain stimulation in patients with medication-refractory essential tremor

    A. Rezaei Haddad, K. Ashkan (Coventry, United Kingdom)

    Objective: To evaluate, for the first time, the safety and efficacy of long-term ventralis intermedius (Vim) constant current deep brain stimulation (DBS) in essential tremor…
  • 2016 International Congress

    Results from a double-blind trial of pallidal DBS for Tourette’s syndrome: Are there any predictors of surgery outcome?

    Z. Kefalopoulou, L. Zrinzo, M. Jahanshahi, J. Candelario, C. Milabo, M. Beigi, H. Akram, J. Hyam, J. Clayton, L. Kass-Iliyya, M. Silverdale, J. Evans, P. Limousin, M. Hariz, E. Joyce, T. Foltynie (London, United Kingdom)

    Objective: To explore whether individual patient characteristics can indicate response to treatment in a trial of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS)…
  • 2016 International Congress

    Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy

    F. Bassil, P.O. Fernagut, E. Bezard, Q. Hoang, D. Ringe, G.A. Petsko, W.G. Meissner (Bordeaux, France)

    Objective: To assess the therapeutic efficacy of the caspase-1 inhibitor prodrug VX-765 on alpha-synuclein (α-syn) pathology and neuroprotection in a transgenic mouse model of multiple…
  • 2016 International Congress

    The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

    M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

    Objective: To examine the extent of disease progression for multiple system atrophy (MSA) during relatively long duration. Background: The knowledge of MSA natural history is…
  • « Previous Page
  • 1
  • …
  • 182
  • 183
  • 184
  • 185
  • 186
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley